Study of peripheral stem cells mobilization as a treatment line of pediatric dilated cardiomyopathy.

Background: Mobilizing hematopoietic stem cells may be a promising intervention for the treatment of idiopathic dilated cardiomyopathy (IDCM) in infant and children. So the aim of the work is to evaluate the efficacy of granulocyte-colony stimulating factor (G-CSF) as a therapeutic modality in pediatric IDCM.

Methods: A randomized clinical trial was conducted on 40 pediatric patients with IDCM.